Long Term Value Investor Analysis of Colgate-Palmolive (CL)
2026-02-04 Colgate-Palmolive is a global consumer staples company built around oral care, personal hygiene, and household products, with toothpaste as […]
Stock Analysis
Long Term Value Investor Analysis of Cogeco Communications (CCA)
2026-02-02 Cogeco Communication CCA.TO provides high speed Internet to residential and business customers. It is a mature, asset heavy Canadian
Long-Term Value Investor Analysis of Bridgemarq Real Estate Services
2026-02-02 NOTICE : I am removing this post as the analysis is not longer valid given recent events. Management cut
Long-Term Value Investor Analysis of American Express (AXP)
2026-02-01 American Express operates a global payments network focused on affluent consumers and premium corporate clients. Unlike Visa and Mastercard,
Shopify: A High-Quality Platform with a Venture Capital Valuation
2026-01-31 Shopify provides software and infrastructure that allow merchants of all sizes to build, operate, and scale online businesses. It
Long-Term Value Investor Analysis of Royal Bank of Canada (RY.TO)
Royal Bank of Canada is the country’s largest financial institution, spanning personal banking, commercial lending, capital markets, wealth management, and
Kinder Morgan (KMI) Under the Microscope: A Value Investor’s Long View on Cash Flows, Moats, and Margin of Safety
2026-01-27 Kinder Morgan is one of North America’s largest energy infrastructure companies, owning and operating natural gas pipelines, refined product
Long-Term Value Investor Analysis of Gilead Sciences (GILD)
Date: 2026-01-26 Gilead Sciences is a research driven biopharmaceutical company focused on antiviral medicines, oncology therapies, and treatments for inflammatory
Long-Term Value Investor Analysis of Pfizer (PFE): High Dividend Value Play or Post Pandemic Trap?
2026-01-26 Pfizer is a global pharmaceutical company that develops, manufactures, and sells patented medicines and vaccines across oncology, immunology, cardiology,
Long-Term Value Investor Analysis of AbbVie (ABBV)
Date: 2026-01-24 AbbVie is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in immunology,
Long-Term Investor Stock Analysis of Bristol Myers Squibb (BMY)
Date: 2026-01-24 Bristol Myers Squibb is a global biopharmaceutical company focused on oncology, immunology, cardiovascular disease, and hematology. It generates
Long-Term Value Investor Stock Analysis of Bird Construction (BDT): Can a Cyclical Builder Deliver Long-Term Value?
Date: 2026-01-23 Bird Construction is a Canadian general contractor specializing in industrial, infrastructure, and institutional construction projects. The company earns